相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current State of Immunotherapy for Treatment of Glioblastoma
Tresa McGranahan et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
Marta Cenciarini et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E. Brown et al.
MOLECULAR THERAPY (2018)
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
Amber J. Giles et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma
Kara W. Moyes et al.
ONCOIMMUNOLOGY (2018)
Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival
Matthew Mason et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide
Jian L. Campian et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2017)
Corticosteroids compromise survival in glioblastoma
Kenneth L. Pitter et al.
BRAIN (2016)
Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma
E. T. Wong et al.
BRITISH JOURNAL OF CANCER (2015)
Suppression of TDO-Mediated Tryptophan Catabolism in Glioblastoma Cells by a Steroid-Responsive FKBP52-Dependent Pathway
Martina Ott et al.
GLIA (2015)
Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline
X. Kostaras et al.
CURRENT ONCOLOGY (2014)
The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity
Anne Kleijn et al.
PLOS ONE (2014)
Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways
Damiano Conte et al.
PLOS ONE (2012)
GM-CSF Production by Glioblastoma Cells Has a Functional Role in Eosinophil Survival, Activation, and Growth Factor Production for Enhanced Tumor Cell Proliferation
Colleen S. Curran et al.
JOURNAL OF IMMUNOLOGY (2011)
Corticosteroids in brain cancer patients: benefits and pitfalls
Jörg Dietrich et al.
Expert Review of Clinical Pharmacology (2011)
Circulating Levels of the Innate and Humoral Immune Regulators CD14 and CD23 Are Associated with Adult Glioma
Mi Zhou et al.
CANCER RESEARCH (2010)
Evaluation of Treatment-Associated Inflammatory Response on Diffusion-Weighted Magnetic Resonance Imaging and 2-[18F]-Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography Imaging Biomarkers
Craig J. Galban et al.
CLINICAL CANCER RESEARCH (2010)
CC-CHEMOKINE LIGAND 18/PULMONARY ACTIVATION-REGULATED CHEMOKINE EXPRESSION IN THE CNS WITH SPECIAL REFERENCE TO TRAUMATIC BRAIN INJURIES AND NEOPLASTIC DISORDERS
C. -Y. Chang et al.
NEUROSCIENCE (2010)
Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line
Haiou Liu et al.
BRAIN RESEARCH (2009)
The Dexamethasone-induced Inhibition of Proliferation, Migration, and Invasion in Glioma Cell Lines Is Antagonized by Macrophage Migration Inhibitory Factor (MIF) and Can Be Enhanced by Specific MIF Inhibitors
Caroline Piette et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Dexamethasone for intracranial neurosurgery and anaesthesia
Brad Hockey et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
Rachel L. Derr et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Induced interleukin-8 expression in gliomas by tumor-associated macrophages
Tse-Ming Hong et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment
Jerome Villeneuve et al.
BRAIN PATHOLOGY (2008)
Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism
Yu-Min Lin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Evaluation of cancer virotherapy with attenuated replicative Semliki Forest virus in different rodent tumor models
Ann-Marie Maatta et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA
Hidemi Yoshida et al.
NEUROSCIENCE RESEARCH (2007)
Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression
Mark Lowenberg et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Dexamethasone inhibits the HSV-tk/ganciclovir bystander effect in malignant glioma cells -: art. no. 32
PA Robe et al.
BMC CANCER (2005)
Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts:: In vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy
H Wang et al.
CLINICAL CANCER RESEARCH (2004)
Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bc1-2 ratio and preventing proteolytic activities
Arabinda Das et al.
MOLECULAR CANCER (2004)
Analysis of the antitumoral mechanisms of lipopolysaccharide against glioblastoma multiforme
EK Won et al.
ANTI-CANCER DRUGS (2003)
Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells
J Shinoda et al.
GLIA (2003)
Dexamethasone and tumor necrosis factor-α act together to induce the cellular inhibitor of apoptosis-2 gene and prevent apoptosis in a variety of cell types
JC Webster et al.
ENDOCRINOLOGY (2002)
Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor
Q Dan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study
B Badie et al.
JOURNAL OF NEUROSURGERY (2000)
Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions
AM Sandmair et al.
CANCER GENE THERAPY (2000)
Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms
CA Kruse et al.
CANCER GENE THERAPY (2000)
分享论文
